SRS

What SRS Means in Everyday Medical Language

SRS stands for Somatostatin Receptor Scintigraphy, which is also called an Octreotide Scan. It is a medical imaging test that helps doctors find certain types of tumors in the body. The test uses a small amount of a radioactive drug called octreotide, which is similar to a natural hormone named somatostatin. This drug is injected into a vein and travels through the bloodstream. Tumor cells that have special receptors for somatostatin attract and hold onto the radioactive octreotide. A special camera detects the radiation from the drug and creates pictures showing where these tumor cells are located.

This test is often used to find neuroendocrine tumors, such as carcinoid tumors or pancreatic neuroendocrine tumors. It may also help locate certain inflammatory conditions like sarcoidosis. Because the names SRS, Octreotide Scan, and Somatostatin Receptor Scintigraphy all refer to the same test, it’s helpful to know they mean the same thing when reading medical reports or talking with your care team.

Why SRS Can Matter in Cancer Care

Neuroendocrine tumors can sometimes be hard to find because they may be small or located in places that are difficult to see with regular imaging tests. The SRS test helps doctors locate these tumors by targeting the somatostatin receptors that many of these tumor cells have. Knowing where tumors are helps doctors plan treatment, monitor how well treatment is working, or check for tumor spread after treatment.

Because the scan highlights tumor cells with somatostatin receptors, it is especially useful for tumors like carcinoid tumors, gastrinomas, glucagonomas, and other neuroendocrine tumors. It can also help detect certain inflammatory conditions such as sarcoidosis. While newer imaging tests using PET scans with different radioactive drugs are sometimes preferred for higher detail, the Octreotide Scan remains an important tool in many settings.

What Patients Might See or Hear About SRS

If your doctor mentions an SRS, you might hear it called by other names like Octreotide Scan or Somatostatin Receptor Scintigraphy. You may see these terms in your medical reports, visit notes, or educational materials. The scan involves an injection of a radioactive drug followed by imaging with a special camera, usually done over several hours or even days to get the best pictures.

Because the scan is a tool to help find tumors, seeing the term does not mean you have a specific diagnosis or that a particular treatment is planned. It is important to ask your healthcare team what the scan results mean for your personal care and what the next steps might be.

How Doctors Use SRS in Diagnosis and Care

Doctors use SRS to locate neuroendocrine tumors that have somatostatin receptors. It can help find the original tumor, check if the cancer has spread, or monitor how well treatment is working. The scan is often part of the diagnosis and staging process and may be repeated during follow-up care.

The radioactive drug used in the scan is usually labeled with indium-111 or technetium-99m, and imaging is done with a gamma camera using a technique called SPECT. This allows doctors to see detailed images of where tumor cells are in the body.

Common Sources of Confusion and How to Read SRS in Context

The term SRS can be confusing because it may appear under different names like Octreotide Scan or Somatostatin Receptor Scintigraphy. These all refer to the same test. It’s important not to treat the word alone as a diagnosis or treatment recommendation. Instead, ask your care team how this test applies to your specific situation.

Seeing the term in a report or discussion means a test was done or planned, but it does not tell you the results or what those results mean for your care. Always discuss with your healthcare provider to understand the purpose and findings of the scan.

Safety and Next Steps

This information is for education and does not decide what is safe, appropriate, or effective for any individual patient. If you see the term SRS or Octreotide Scan in your medical records or hear it mentioned, the best next step is to ask your care team what it means for your specific case. They can explain how the test fits into your diagnosis, treatment plan, or follow-up care.